{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:40:12Z","timestamp":1789400412431,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypothyroidism, both overt and subclinical, is associated with dyslipidemia and increased cardiovascular risk which is not completely corrected by thyroid hormone replacement therapy. In patients with subclinical hypothyroidism, when TSH levels are &amp;lt;10 mIU\/L, dyslipidemia is considered a relative indication for establishment of replacement therapy. Although reasonable, the evidence supporting this approach is limited, and the results are conflicting. Here we present the results of a retrospective study directed to assess the differences in lipid metabolism parameters between patients with subclinical hypothyroidism treated or untreated with levothyroxine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-center, retrospective cohort study. Patients with diagnosis of mild subclinical hypothyroidism not taking thyroid hormone replacement therapy (at baseline) and at least two measurements of TSH and lipid panel were included in the analysis. Patients taking lipid lowering therapies were excluded from the study. Primary endpoints were changes in TSH, total and LDL cholesterol between patients treated and untreated with thyroid hormone replacement therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-two patients (14 treated and 38 untreated) median age 61.0 years and body mass index 27.0 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      were included in the analysis. Median baseline TSH and LDL-cholesterol were 5.6 mIU\/L and 121.0 mg\/dL, respectively. At follow up, median TSH decreased in both groups (treated -2.5 mIU\/L [95% CI: -3.8, -1.2] untreated -1.7 mIU\/L [-2.6, -0.8] p&amp;lt;0.001). Median total and LDL-cholesterol significantly increased in the treated group (7.8 mg\/dL [2.2, 13.5] p=0.01 and 13.2 mg\/dL [1.4, 25.1] p=0.03, respectively), while the untreated group saw no changes. No changes were observed in HDL-cholesterol and triglycerides for either group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicate that in patients affected by mild subclinical hypothyroidism not receiving lipid lowering treatments, levothyroxine therapy was associated with increase in total cholesterol and LDL-cholesterol, while this did not occur in untreated patients. One possible explanation of this counterintuitive finding is the inhibition of endogenous thyroid hormone production with further reduction of T3-mediated metabolic on lipid metabolism. Prospective interventional studies are needed to confirm this observation, potentially changing the approach to the treatment of subclinical hypothyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1847857","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:25:15Z","timestamp":1782793515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism"],"prefix":"10.3389","volume":"17","author":[{"given":"Rachel","family":"Zielinski","sequence":"first","affiliation":[{"name":"Department of Medicine, UConn Health","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane J.","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Medicine, UConn Health","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Dillon","sequence":"additional","affiliation":[{"name":"Department of Medicine, UConn Health","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Katsetos","sequence":"additional","affiliation":[{"name":"Department of Medicine, UConn Health","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco S.","family":"Celi","sequence":"additional","affiliation":[{"name":"Department of Medicine, UConn Health","place":["Farmington, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101629","article-title":"Association of longitudinal changes in serum lipids with the natural history of subclinical hypothyroidism: a retrospective cohort study using data from the REACTION study","volume":"53","author":"Zhong","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12939","article-title":"Natural history of subclinical hypothyroidism with TSH <\/=10 mIU\/l: a prospective study","volume":"84","author":"Rosario","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0414","article-title":"Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"28","author":"Moon","year":"2018","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.03.371","article-title":"Relation of subclinical hypothyroidism is associated with cardiovascular events and all-cause mortality in adults with high cardiovascular risk","volume":"122","author":"Moon","year":"2018","journal-title":"Am J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.13338","article-title":"The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"87","author":"Li","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01361","article-title":"Systemic thyroid hormone status during levothyroxine therapy in hypothyroidism: a systematic review and meta-analysis","volume":"103","author":"McAninch","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022552","article-title":"Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients","volume":"6","author":"Gullo","year":"2011","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.07.023","article-title":"Lower serum triiodothyronine levels constitute an independent risk factor for dyslipidemia in levothyroxin-treated patients","volume":"32","author":"Penna","year":"2026","journal-title":"Endocr Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1901214","article-title":"Drug effects on the thyroid","volume":"381","author":"Burch","year":"2019","journal-title":"N Engl J Med"},{"key":"B15","volume-title":"R: a language and environment for statistical computing","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"376","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2796.2006.01652.x","article-title":"Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso study","volume":"260","author":"Iqbal","year":"2006","journal-title":"J Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1094044","article-title":"Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study","volume":"31","author":"Liu","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0010","article-title":"A worthy finding: decrease in total cholesterol and low-density lipoprotein cholesterol in treated mild subclinical hypothyroidism","volume":"26","author":"Zhao","year":"2016","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1522753","article-title":"A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism","volume":"16","author":"Phan","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00371","article-title":"Combination therapy for hypothyroidism: rationale, therapeutic goals, and design","volume":"11","author":"Madan","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000512970","article-title":"Evidence-based use of levothyroxine\/liothyronine combinations in treating hypothyroidism: a consensus document","volume":"31","author":"Jonklaas","year":"2021","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/1028415x.2016.1236174","article-title":"Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury","volume":"21","author":"Lucke-Wold","year":"2018","journal-title":"Nutr Neurosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1847857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:25:15Z","timestamp":1782793515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1847857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":24,"alternative-id":["10.3389\/fendo.2026.1847857"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1847857","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1847857"}}